Glaucoma: The Silent Thief of Sight

Glaucoma: The Silent Thief of Sight

Glaucoma is not a single disease but a group of eye conditions characterised by progressive optic neuropathy — damage to the optic nerve, the cable that carries visual information from the retina to the brain. As retinal ganglion cells (the neurons whose axons form the optic nerve) progressively die, the visual field is eroded from the periphery inwards, ultimately leading to tunnel vision and, untreated, blindness.

Glaucoma is the leading cause of irreversible blindness worldwide, affecting approximately 80 million people. Unlike cataracts, the vision lost to glaucoma cannot be restored. The crucial challenge is that glaucoma is almost entirely asymptomatic until significant, permanent damage has already occurred — earning it the title "the silent thief of sight." Regular screening in at-risk populations is the cornerstone of prevention.

How Glaucoma Damages the Eye

Aqueous Humour and Intraocular Pressure

The eye maintains its shape and pressure through the production and drainage of aqueous humour — a clear fluid produced by the ciliary body, which flows from the posterior chamber, through the pupil, and drains from the anterior chamber via the trabecular meshwork (a spongy tissue at the drainage angle between the iris and cornea) into the Schlemm's canal and episcleral veins.

Intraocular pressure (IOP) is determined by the balance between aqueous production and drainage. The average normal IOP is 15 mmHg (normal range: 10–21 mmHg). Elevated IOP — the most important risk factor for glaucoma — occurs when aqueous drainage is impaired.

How Elevated IOP Damages the Optic Nerve

Elevated IOP compresses the optic nerve head (optic disc) at the point where the nerve fibres exit the eye through the lamina cribrosa — a fenestrated plate of connective tissue that provides structural support for the nerve fibres. Mechanical compression and impaired axoplasmic transport (nutrients flowing along axons) kill retinal ganglion cells. The optic disc develops characteristic changes:

• Increased cup-to-disc ratio (CDR): the cup (central depression) enlarges relative to the disc; CDR >0.6 or asymmetry between eyes is suspicious
• Neuroretinal rim thinning: glaucomatous damage typically causes rim thinning and cupping. Pallor of the remaining rim, especially when disproportionate to cupping, can suggest another optic neuropathy and needs specialist assessment.
• Notching: focal loss of the neuroretinal rim, typically at the inferior or superior poles first
• RNFL defects: retinal nerve fibre layer thinning visible on OCT imaging

Important exception: approximately 30–40% of glaucoma patients have optic nerve damage with IOP within the normal range — normal-tension glaucoma (NTG). Vascular factors, reduced optic nerve perfusion, and individual susceptibility of the optic disc play important roles.

Types of Glaucoma

Primary Open-Angle Glaucoma (POAG) — Most Common

The drainage angle between the iris and cornea is anatomically open, but the trabecular meshwork is dysfunctional — drainage resistance is increased, IOP rises slowly over years. POAG is the most common form in White and Black populations worldwide.

Characteristics:

• Slow, painless onset — no symptoms until advanced
• Bilateral, though often asymmetric
• Progressive peripheral visual field loss (scotomas), typically starting as small areas of reduced sensitivity that coalesce into arcuate defects, then nasal steps, ultimately sparing only central vision
• IOP typically elevated but can be normal (NTG)

Risk factors for POAG: age (risk doubles each decade after 40); elevated IOP; thin central cornea (thinner cornea means true IOP may be underestimated); myopia (particularly high myopia); Black African or Caribbean ethnicity (3–4× increased risk, earlier onset, more aggressive); positive family history (4× risk if first-degree relative affected); optic disc findings (large disc, large cup).

Primary Angle-Closure Glaucoma (PACG)

The anatomical drainage angle between the iris and cornea is narrow or closed, physically obstructing aqueous outflow. More common in East Asian populations (Chinese, Vietnamese, Thai), hyperopic (far-sighted) patients, and women.

Chronic angle closure: Insidious, similar to POAG but with a narrow drainage angle; often discovered incidentally.

Acute angle-closure crisis (glaucoma attack): Rapid, complete closure of the drainage angle causes sudden severe IOP elevation (50–80 mmHg), producing:

• Sudden, severe eye pain — may radiate to the forehead or cause headache and nausea/vomiting (mimicking migraine or acute abdomen)
• Sudden visual blurring and halos around lights
• Red eye (conjunctival injection)
• Fixed, semi-dilated, unreactive pupil
• Rock-hard eye on palpation
• Medical emergency: vision can be permanently lost within hours; immediate treatment required

Secondary Glaucomas

• Pseudoexfoliation glaucoma: fibrillar material deposits on the lens and clogs the trabecular meshwork; associated with high IOP and rapid progression; more common in Scandinavian and Middle Eastern populations
• Pigmentary glaucoma: pigment granules shed from the iris clog the meshwork; young myopic men; IOP spikes with exercise
• Neovascular glaucoma: new blood vessel proliferation (from diabetic retinopathy or CRVO) closes the drainage angle; very high IOP; poor prognosis
• Steroid-induced glaucoma: topical, systemic, or intravitreal corticosteroids can raise IOP in genetically susceptible individuals ("steroid responders")
• Traumatic glaucoma: blunt trauma damages the trabecular meshwork (angle recession glaucoma)

Diagnosis

Early diagnosis requires active case-finding — most patients are asymptomatic.

Intraocular Pressure Measurement (Tonometry)

Goldmann applanation tonometry — the gold standard; measures the force required to flatten a standard area of the cornea. IOP varies throughout the day (diurnal variation); single readings can miss elevated IOP.

Pachymetry — central corneal thickness measurement; thin corneas underestimate true IOP; thick corneas overestimate IOP.

Optic Disc Examination

Slit-lamp biomicroscopy with a fundus lens examines the optic disc for cup-to-disc ratio, neuroretinal rim appearance, disc haemorrhages (a sign of active damage), and peripapillary atrophy.

Optical coherence tomography (OCT) — the most sensitive structural test. OCT quantifies:

• Retinal nerve fibre layer (RNFL) thickness — compared to normative databases
• Ganglion cell complex (GCC) analysis — detects macular ganglion cell loss
• Optic disc parameters (CDR, rim area)

OCT can detect structural damage before visual field defects appear (pre-perimetric glaucoma).

Visual Field Testing (Perimetry)

Standard automated perimetry (Humphrey visual field analyser) maps the patient's visual field by presenting light stimuli at standardised locations. Glaucomatous defects follow the arcuate pattern of retinal nerve fibre bundles. Regular visual field testing every 6–12 months is essential to monitor progression.

Gonioscopy

A special mirrored contact lens allows direct visualisation of the drainage angle — essential to classify glaucoma as open-angle or closed-angle and guide treatment decisions.

Treatment

Eye Drop Therapy

Lowering intraocular pressure (IOP) is central to reducing the risk of glaucomatous progression. In an analysis of the Early Manifest Glaucoma Trial, each 1 mmHg reduction from baseline to the first follow-up visit was associated with about a 10% lower progression hazard (hazard ratio 0.90). This study association is not a universal formula or an individual guarantee; target pressure depends on the person’s disease and risk.

Drug Class	Example	IOP Reduction	Mechanism
Prostaglandin analogues	Latanoprost, bimatoprost, travoprost	25–33%	Increases uveoscleral outflow; once daily
Beta-blockers	Timolol, betaxolol	20–25%	Reduces aqueous production; avoid in asthma
Alpha-2 agonists	Brimonidine	20–25%	Reduces aqueous production; increases outflow
Carbonic anhydrase inhibitors	Dorzolamide, brinzolamide	15–20%	Reduces aqueous production
Rho-kinase inhibitors	Netarsudil	20–25%	Increases trabecular outflow; newer class
Combination drops	Xalacom, DuoTrav	30–35%	Two agents in one bottle; improves adherence

Prostaglandin analogues are first-line in most patients — once-daily dosing and greatest IOP-lowering effect. Adherence is the primary challenge in chronic glaucoma management.

Laser Treatment

Selective laser trabeculoplasty (SLT): Laser treatment of the trabecular meshwork improves drainage and can be a first-line option for suitable open-angle glaucoma. Average pressure reductions of about 20–30% have been reported, but response and duration vary. The effect can wear off and repeat treatment may be considered. SLT does not require an incision, but it is not risk-free: temporary pressure rises, inflammation and blurred vision can occur; rarely, further treatment is needed for a marked pressure rise.

Peripheral laser iridotomy (LPI): A small opening in the iris allows fluid to bypass pupillary block. It can treat or reduce the risk of angle closure in selected patients. It does not reverse existing optic-nerve damage or remove every cause of angle closure; pressure-lowering medicines, lens extraction or other treatment may still be needed. Acute symptoms require emergency eye assessment.

Surgery

When eye drops and laser fail to achieve target IOP or disease progresses despite treatment:

Trabeculectomy — the classic glaucoma filtration surgery. A scleral flap is created, a small section of the trabecular meshwork is removed, and aqueous drains from the anterior chamber into a subconjunctival bleb (a fluid-filled blister under the conjunctiva), from where it is absorbed. Highly effective — can reduce IOP to 8–12 mmHg. Complications: bleb infection (blebitis, endophthalmitis), hypotony, cataract acceleration.

Glaucoma drainage devices (tube shunts): A tube is placed in the anterior chamber connecting to a plate sutured to the sclera. Used when trabeculectomy is likely to fail (previous surgery, severe conjunctival scarring, neovascular glaucoma). Examples: Baerveldt, Ahmed, Molteno implants.

Minimally invasive glaucoma surgery (MIGS): Procedures differ in mechanism, pressure-lowering effect and risk. Some are combined with cataract surgery, while others can be performed alone in selected patients. Examples include iStent Inject and Hydrus Microstent (trabecular bypass), and XEN gel stent (subconjunctival drainage). The specific device, indication and local authorisation must be checked; these procedures are not interchangeable.

Acute angle-closure crisis management: IV acetazolamide, IV mannitol, topical beta-blocker and alpha-agonist to rapidly lower IOP; followed by laser iridotomy once the acute episode is controlled.

Glaucoma Care in China

Before arranging glaucoma care in China, ask the receiving team to confirm:

• Which tests are needed, such as tonometry, OCT, visual fields, corneal thickness measurement and gonioscopy.
• Whether repeated pressure measurements or longer monitoring would help in the individual case.
• The appropriate drops, laser or surgery, and the actual availability of any proposed device.
• The clinician’s relevant experience and the expected benefits, risks and follow-up requirements.
• The hospital’s emergency arrangements, itemised quote and separately agreed PriumCare coordination scope.

Sudden severe eye pain, redness or visual loss requires immediate local emergency assessment; do not wait for travel coordination.

Contact a PriumCare care navigator to arrange a glaucoma assessment, IOP monitoring, or surgical consultation.

---

Sources for these targeted corrections

• NEI: glaucoma.
• Early Manifest Glaucoma Trial progression analysis.
• Moorfields: selective laser trabeculoplasty.
• East Sussex Healthcare NHS: SLT information.
• Moorfields: peripheral laser iridotomy.
• XEN implant study: standalone and combined surgery.

Editorial source correction: 25 October 2026. This targeted check addressed flagged diagnosis, treatment-selection, procedural-risk and availability claims. It is not a clinical review of the whole article. No named medical reviewer is claimed. Original publication date is retained.

Targeted optic-disc appearance clarification

Editorial source check: 26 October 2026. This update checks only the distinction between glaucomatous rim thinning/cupping and pallor suggesting another optic neuropathy described above. It is not a whole-article medical review, adds no named clinical reviewer, and retains the original publication date.

• World Glaucoma Association: optic-nerve structure consensus points
• AAO: differentiating glaucomatous and other optic neuropathies